CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
International Stem Cell Corporation  (ISCO)
Other Ticker:  
 

Cumulative International Stem Cell's Working Capital Ratio for Trailing Twelve Months Period

ISCO's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

ISCO Working Capital Ratio for Trailing Twelve Months Period

 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 1.5 % 1.07 % 0.42 % 8.19 % 6.07 %
Y / Y Current Assets Growth 35.48 % 23.05 % 9.32 % 26.95 % 8.61 %
Working Capital Ratio for Trailing Twelve Months Period 0.72 0.67 0.63 0.62 0.6
Total Ranking # 3327 # 3552 # 3821 # 4398 # 4216
Seq. Current Liabilities Growth -1.31 % -1.8 % 4.23 % 0.48 % -1.73 %
Seq. Current Assets Growth -0.71 % 13.84 % 9.21 % 9.74 % -9.82 %

ISCO Segments >> Back to ISCO Financial Strength Comparisons >> Compare ISCO Debt to Equity Ratio to its Competitors

Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis International Stem Cell Corporation Current Assets average grew by 35.48% in III. Quarter year on year, faster than Current Liabilities, this led to increase in in International Stem Cell's Working Capital Ratio for Trailing Twelve Months Period to 0.72, Working Capital Ratio for Trailing Twelve Months Period remained below International Stem Cell Corporation average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 456 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than International Stem Cell. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about ISCO
Working Capital Ratio ISCO in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 457
Sector # 932
S&P 500 # 3268


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.99 0.65 0.32
(Sep. 30, 2014)   (Sep 30 2016)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Oculis Holding Ag  1.97 
Apexigen Inc   1.97 
Biofrontera Inc   1.96 
Transcode Therapeutics Inc   1.94 
Precigen Inc   1.94 
Lifevantage Corp  1.92 
Mira Pharmaceuticals Inc   1.91 
Scisparc Ltd   1.91 
Inventiva S a   1.91 
Spyre Therapeutics Inc   1.91 
Puma Biotechnology Inc   1.89 
Cellectar Biosciences inc   1.88 
Fibrogen Inc   1.88 
Ascendis Pharma A  1.86 
Veru Inc   1.85 
Medicure Inc   1.84 
Amneal Pharmaceuticals Inc   1.84 
Galectin Therapeutics Inc   1.83 
Aravive Inc   1.82 
Maravai Lifesciences Holdings Inc   1.82 
Pfizer Inc  1.79 
Cti Biopharma Corp   1.77 
Opko Health Inc   1.76 
Rockwell Medical inc   1.76 
Eagle Pharmaceuticals inc   1.76 
Lifecore Biomedical Inc   1.72 
Conduit Pharmaceuticals Inc   1.71 
Supernus Pharmaceuticals inc   1.70 
Myovant Sciences Ltd   1.70 
Abbott Laboratories  1.70 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com